The U.S. warts treatment market is projected to register a substantial CAGR of 8.2% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
U.S. Warts Treatment Market, By Type (Common Warts (Verruca Vulgaris), Genital Warts, Plantar Warts, Flat Warts, Filiform Warts, Periungual Warts, Others), Treatment (Medication, Therapy, Laser Treatment, Surgery, Cantharidin, Candida Antigen Shots, Acupuncture, Others), Product (Prescription, Over the Counter (OTC)), Dosage Form (Creams, Liquid, Gels, Injectable Solutions, Pads, Tape, Others), End User (Dermatology Centers, Specialty Clinics, Hospitals, Homecare, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the U.S. warts treatment market are:

• Increasing awareness about warts
• High investment on R&D in the warts treatment market

Market Players:

The key market players for the U.S. warts treatment market are listed below:

• Bausch Health Companies Inc.
• Dr. Reddy’s Laboratories Ltd.
• Almirall, S.A
• Merck Sharp & Dohme Corp. (A Subsidiary of Merck & Co., Inc.)
• Prestige Consumer Healthcare, Inc.
• Aclaris Therapeutics, Inc.
• Bako Diagnostics
• Bristol-Myers Squibb Company
• CryoPen, Inc.
• CryoSurgery, Inc.
• EPI Health
• Emblation Ltd.
• Fotona
• Nielsen Biosciences
• Novan, Inc.
• Nowarta Biopharma, Inc.
• Perrigo Company plc
• Peritech Pharma
• Vaxart, Inc.
• Verrica Pharmaceuticals